MedTrace Logo

Exercise for Fighting Oncology Repercussions After Treatment

NCT05980325 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-12-06

No results posted yet for this study

Summary

Cancer survival rates are currently on the verge of 70% at 5 years since diagnosis. Recent improvements in main cancer therapies including chemotherapy, radiotherapy, surgery and immunotherapy as well as developments of new biological therapies have significantly improved survival rates but unfortunately, cancer-related side effects continue to affect many patients even years after completion of main treatments. Exercise has been shown to not only ameliorate cancer-related effects before, during and after treatment but also improve disease-free and overall survival rates by decreasing risk factors associated with cancer risk and improving resilience to treatment. In this non-randomised, three-arm study, we aim to assess the effects of three forms of exercise (i.e: Nordic Walking, Aquatic Exercise and Functional Exercise) on physical performance, cancer-related fatigue, health-related quality of life and cancer-specific symptoms in a wide range of cancer survivors.

Conditions

  • Neoplasms

Interventions

BEHAVIORAL

Nordic Walking

A 12-week Nordic Walking exercise programme supervised twice weekly

BEHAVIORAL

Aquatic Exercise

A 12-week water-based exercise training programme supervised twice weekly

BEHAVIORAL

Functional Exercise Training

A 12-week circuit-based exercise training programme supervised twice weekly

Sponsors & Collaborators

  • Col·legi de Fisioterapeutes de Catalunya

    collaborator UNKNOWN

  • Ajuntament de Mataró

    collaborator UNKNOWN

  • Universitat Pompeu Fabra

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-08
Primary Completion
2026-01-01
Completion
2026-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05980325 on ClinicalTrials.gov